C WorldWide Group Holding A/S - Q2 2016 holdings

$5.22 Billion is the total value of C WorldWide Group Holding A/S's 163 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .

 Value Shares↓ Weighting
UNH  UNITEDHEALTH GROUP INC$48,031,000
+9.5%
340,1580.0%0.92%
+8.5%
PFE  PFIZER INC$40,453,000
+18.8%
1,148,9150.0%0.77%
+17.5%
JNJ  JOHNSON & JOHNSON$32,446,000
+12.1%
267,4860.0%0.62%
+10.9%
MRK  MERCK & CO INC$11,775,000
+8.9%
204,3970.0%0.22%
+7.7%
HCA  HCA HOLDINGS INC$11,172,000
-1.3%
145,0750.0%0.21%
-2.3%
BMRN  BIOMARIN PHARMACEUTICAL INC$8,369,000
-5.7%
107,5750.0%0.16%
-7.0%
DVA  DAVITA HEALTHCARE PARTNERS I$7,399,000
+5.4%
95,6910.0%0.14%
+4.4%
COO  COOPER COS INC$7,360,000
+11.4%
42,9000.0%0.14%
+10.2%
ABBV  ABBVIE INC$6,655,000
+8.4%
107,5000.0%0.13%
+6.7%
ABC  AMERISOURCEBERGEN CORP$5,163,000
-8.4%
65,1000.0%0.10%
-9.2%
RLYP  RELYPSA INC$4,958,000
+36.5%
268,0000.0%0.10%
+35.7%
CPHD  CEPHEID$3,610,000
-7.8%
117,4000.0%0.07%
-9.2%
DXCM  DEX INC$3,604,000
+16.8%
45,4250.0%0.07%
+15.0%
AERI  AERIE PHARMACEUTICALS INC$3,379,000
+44.7%
192,0060.0%0.06%
+44.4%
INCY  INCYTE CORP$3,279,000
+10.4%
41,0000.0%0.06%
+10.5%
PODD  INSULET CORP$3,266,000
-8.8%
108,0000.0%0.06%
-8.7%
VRX  VALEANT PHARMACEUTICALS INTL$3,252,000
-23.4%
161,4610.0%0.06%
-24.4%
EXAS  EXACT SCIENCES CORP$3,062,000
+81.7%
250,0000.0%0.06%
+78.8%
SPNC  SPECTRANETICS CORP$2,993,000
+28.8%
159,9560.0%0.06%
+26.7%
KERX  KERYX BIOPHARMACEUTICALS INC$2,788,000
+41.7%
421,1100.0%0.05%
+39.5%
KITE  KITE PHARMA INC$2,350,000
+8.9%
47,0000.0%0.04%
+7.1%
INGR  INGREDION INC$2,226,000
+21.2%
17,2000.0%0.04%
+19.4%
FIS  FIDELITY NATL INFORMATION SV$2,077,000
+16.4%
28,2000.0%0.04%
+14.3%
CERN  CERNER CORP$1,746,000
+10.6%
29,8000.0%0.03%
+6.5%
VRTX  VERTEX PHARMACEUTICALS INC$1,660,000
+8.2%
19,3000.0%0.03%
+6.7%
INNL  INNOCOLL HLDGS PLC$1,626,000
-35.8%
295,1840.0%0.03%
-36.7%
FLKS  FLEX PHARMA INC$1,532,000
-6.9%
150,0000.0%0.03%
-9.4%
NVDQ  NOVADAQ TECHNOLOGIES INC$1,476,000
-11.3%
150,0000.0%0.03%
-12.5%
PCG  PG&E CORP$1,484,000
+7.1%
23,2100.0%0.03%
+3.7%
AGTC  APPLIED GENETIC TECHNOL CORP$1,462,000
+1.0%
103,5000.0%0.03%0.0%
JPM  JPMORGAN CHASE & CO$1,399,000
+5.0%
22,5000.0%0.03%
+3.8%
SRNE  SORRENTO THERAPEUTICS INC$1,249,000
+4.1%
222,9810.0%0.02%
+4.3%
MDLZ  MONDELEZ INTL INCcl a$1,206,000
+13.3%
26,5000.0%0.02%
+9.5%
PTLA  PORTOLA PHARMACEUTICALS INC$1,216,000
+15.7%
51,5130.0%0.02%
+15.0%
ADP  AUTOMATIC DATA PROCESSING IN$1,102,000
+2.4%
12,0000.0%0.02%0.0%
MD  MEDNAX INC$1,064,000
+12.0%
14,7000.0%0.02%
+11.1%
REGN  REGENERON PHARMACEUTICALS$1,023,000
-3.1%
2,9300.0%0.02%0.0%
SNA  SNAP ON INC$999,000
+0.5%
6,3300.0%0.02%0.0%
RDUS  RADIUS HEALTH INC$710,000
+16.8%
19,3300.0%0.01%
+16.7%
KMPH  KEMPHARM INC$657,000
-72.5%
165,0000.0%0.01%
-71.7%
ACAD  ACADIA PHARMACEUTICALS INC$662,000
+16.1%
20,3900.0%0.01%
+18.2%
VNTV  VANTIV INCcl a$645,000
+5.0%
11,4000.0%0.01%0.0%
OXFD  OXFORD IMMUNOTEC GLOBAL PLC$634,000
-9.2%
70,4600.0%0.01%
-14.3%
XLRN  ACCELERON PHARMA INC$557,000
+28.6%
16,4000.0%0.01%
+37.5%
LLY  LILLY ELI & CO$560,000
+9.6%
7,1000.0%0.01%
+10.0%
ICPT  INTERCEPT PHARMACEUTICALS IN$542,000
+11.1%
3,8000.0%0.01%
+11.1%
PTCT  PTC THERAPEUTICS INC$447,000
+9.0%
63,7000.0%0.01%
+12.5%
ACOR  ACORDA THERAPEUTICS INC$255,000
-3.4%
10,0000.0%0.01%0.0%
ESPR  ESPERION THERAPEUTICS INC NE$188,000
-41.4%
19,0000.0%0.00%
-33.3%
NLNK  NEWLINK GENETICS CORP$149,000
-38.2%
13,2350.0%0.00%
-40.0%
INFI  INFINITY PHARMACEUTICALS INC$54,000
-74.8%
40,6800.0%0.00%
-75.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-07-29
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC40Q2 202415.5%
THERMO FISHER SCIENTIFIC INC40Q2 202411.2%
HDFC BANK LTD40Q2 20243.7%
ICICI BK LTD40Q2 20242.1%
CENTENE CORP DEL40Q2 20240.4%
DEX INC40Q2 20240.6%
BIOMARIN PHARMACEUTICAL INC40Q2 20240.4%
VERTEX PHARMACEUTICALS INC40Q2 20240.4%
INSULET CORP40Q2 20240.5%
TAIWAN SEMICONDUCTOR MFG LTD39Q2 20241.4%

View C WorldWide Group Holding A/S's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-07-31
13F-HR2024-05-03
13F-HR2024-02-05
13F-HR2023-11-03
13F-HR2023-08-02
13F-HR2023-05-02
13F-HR2023-02-03
13F-HR2022-11-03
13F-HR2022-08-02
13F-HR2022-05-04

View C WorldWide Group Holding A/S's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (5223429000.0 != 5223426000.0)

Export C WorldWide Group Holding A/S's holdings